Navigation Links
BiStim

ProductsBiStim
Company Magstim Company US LLC
Item BiStim
Features 
Description BiStim provides an effective upgrade path that allows users to take full advantage of the Magstim 200 modularity. The potential to combine two units offers fully programmable paired pulse stimulation through a single stimulating coil. The ability to change pulse intervals and to control independently the power level of each Magstim 200 allows for sub- and supra-threshold conditioning and secondary pulses to investigate inhibitory and facilitatory circuits. Two inter pulse spacing options offering maximum controllability -- 1ms - 999ms in 1ms increments or1.0ms - 99.9ms in 0.1ms increments. BiStim has the added advantage of the ability to summate the two single pulses provided by the Magstim stimulators to produce a single High Power pulse equal to 113%* of a single Magstim 200. BiStim remote control coil options allow complete 'single handed' system control allowing: manipulation of amplitude of both stimulators and inter pulse spacing The inter pulse spacing of the two pulses is adjustable using either the integral stimulator controls, remote control coil or externally via triggering software, offering complete user flexibility. The BiStim can be upgraded to provide increased stimulation power equivalent to that of the Magstim 250. Please contact your local distributor or Magstim-us direct on reza.jalinous@magstim.com
Info Magstim Company US LLC
Customer Service: (781) 933-3933
Web site: http://www.magstim-us.com

Related medicine products :

1. Nagahara Nucleus Chopper - Left
2. Nagahara Nucleus Chopper - Right
3. Kelman Nucleus Cracker
4. Osher Nucleus Manipulator - Straight
5. Drysdale Nucleus Manipulator
6. Osher Nucleus Manipulator - Angled
7. Kellan Nucleus Rotator
8. Bechert Nucleus Rotator
9. Mackool-Bechert Nucleus Rotator
10. Kelman Nucleus Rotator
11. Bloomberg Nucleus Rotator and Capsule Retractor
TAG: BiStim
The Vitatron Excellence + lead series are endocardial leads providing excellent handling and optimal pacing characteristics.
The family of Passive Plus DX passive-fixation leads features a 5 mm tip, designed to increase current density and pacing impedance, and a tine fixation, offering versatility and security in lead pla
Selute Picotip Atrial-J steroid eluting passive fixation lead
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),
Medicine Products:
(Date:7/25/2008)...ormer McKesson Corporation Executive, Robert J. Re...ewswire/ -- Aethon Inc.,( http://www.aethon.com ),...ital supply chain logistics, today announced that ...Vice President -- Chief Financial Officer., Reill... Manager for,McKesson Corporation,s Specialty Phar...
(Date:7/25/2008)... HOUSTON, July 25 /PRNewswire/ -- The Elekta Fami... cancer treatment solutions at the 2008,American A... meeting,demonstrating how the joint forces of El...diation therapy planning and delivery solutions th...tter experience for,patients, as well as enhance c...
(Date:7/25/2008)... CARLSBAD, Calif., July 25 /PRNewswire/ -- AutoGe...egistration statement on Form S-1 with the,Securit...ed initial public,offering of shares of its common... offered, all of which are expected to be offered ... offering, have not yet been,determined., J.P. Mo...
(Date:7/25/2008)...turday can be toughest for those trying to drop po...ealthDay News) -- Anyone who has avoided Monday mo...ends are not a dieter,s friend. , Now, research...ts about weekends being their undoing: Most people...ing to lose weight. , "Weekend indulgences can ...
Breaking Medicine News(10 mins):Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3
...established in the near future for those suffering...DS //. Health Minister Mary Harney said that he ...on of a Bill to address insurance difficulties fac...e diseases while administering blood and blood pro...
... Council is seeking various opinions on the issue ...ips with former patients //without fear of a ban. ...d to be extremely careful and remind them that the... be considered inappropriate. In a move that nul...
...epressant that had been linked to heart abnormalit...German researchers told a European fertility confe... found no increased risk and that women might have...ncies fearing that the drug could affect their bab...
...ed three doctors of the Indraprastha Apollo Hospit...d information //on the condition of Rahul Mahajan,...tion of suspected drug overdose. "We have summone...n," said Suman Nalwa, assistant commissioner of po...
Other Medicine News:Health News:Police Summoned Apollo Doctors in Rahul Mahajan’s Cas 2
(Date:7/23/2008)...ork with Protein Therapeutics that Modul...BRIDGE, Mass., July 23 /- Taligen The...corporate growth plan with the,appointment of Abbi...the,establishment of its headquarters in Cambridge..., a co-founder of the company who remains presiden...
(Date:7/22/2008)...ment Plan Completed Successfully, DUBLIN, Ireland...tion,plc (NASDAQ: AMRN ) today announced that the...ood and Drug Administration (FDA) to discuss the,C... of,hypertriglyceridemia. Following these discussi...101 in hypertriglyceridemia., Dr. Declan Doogan, ...
(Date:7/22/2008)... 22 /- Hyperion,Therapeutics, Inc. to...ment,in its Phase 1/2 clinical trial to evaluate t...ects of HPN-100 (formally called GT4P) versus,BUPH...rea cycle disorders,(UCD). The company plans to an...his year., (Logo: http://www.newscom.com/cgi-bin...
(Date:7/22/2008)...enetic Risk Based on Clinical Data, Preventive ...als, WALTHAM, Mass., July 22 /PRNewswire-FirstCal...day announced the launch of an enhanced test repor... Heart Health Genetic Test.,The test is currently ...lth,Genetic Test by Quixtar/Amway. The new report ...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Healthcare M 26A Activity on the Rise 9649 1Healthcare M 26A Activity on the Rise 9649 2BD Announces Webcast of Annual Meeting of Shareholders 9646 1New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 1New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 2New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 3New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 4New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 5New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 6OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 1OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 2
...DIEGO--(BUSINESS WIRE)--Mar 14, 2007 - Sequenom, I...RAY(R) technology and,iPLEX(TM) assay were used by...stitutions and, in independent studies, significan... and drug-resistant,malaria. Results from several ...ed peer-reviewed journals as follows:, -- In "High...
...LADELPHIA, March 15, 2007-- The cause of one notor...to treat the ongoing,threat of another childhood d...ncer Research, researchers from Stony Brook Univer...-- form of poliovirus,is effective in obliterating...had been previously vaccinated against the virus. ...
Other Medicine Technology:Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 2Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 2Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 4